morning powder acid dairy detergent
diversey australia pty. limited - sulfamic acid - soluble powder - sulfamic acid mineral-sulfur-acid active 965.0 g/kg - dairy cleanser - milking equipment | milking machine - milkstone removal | milk fat | milk protein | mineral deposits
morning liquid acid dairy detergent
diversey australia pty. limited - dodicin; phosphoric acid - aqueous concentrate - dodicin amino acid-glycine active 12.5 g/l; phosphoric acid mineral-phosphorus-acid active 600.0 g/l - dairy cleanser - milking equipment | milking machine - milkstone removal | milk fat | milk protein | mineral deposits
betamethasone dipropionate usp, 0.05% ointment
trupharma llc - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
clotrimazole topical solution usp, 1% solution
trupharma llc - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - prescription clotrimazole topical solution product is indicated for the topical treatment of candidiasis due to candida albicans and tinea versicolor due to malassezia furfur . this formulation is also available as a nonprescription product which is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes , epidermophyton fluoccosum , and microsporum canis . topical antifungal agents are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
cerave itch relief moisturizing- pramoxine hydrochloride lotion
valeant pharmaceuticals north america llc - pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - pramoxine hydrochloride 1 mg in 1 ml - external analgesic for the temporary relief of itching associated with minor skin irritations.
cerave itch relief moisturizing cream- pramoxine hydrochloride cream
valeant pharmaceuticals north america llc - pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - pramoxine hydrochloride 10 mg in 1 g - external analgesic for the temporary relief of itching associated with minor skin irritations.
livrelief nerve pain relief capsicum annuum cream
livcorp inc. - capsicum (unii: 00uk7646fg) (capsicum - unii:00uk7646fg) - capsicum 2 [hp_c] in 50 g
l-methyl-b6-b12- levomefolate calcium, pyridoxal phosphate anhydrous, and methylcobalamin tablet, coated
avkare, inc. - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w) - levomefolate calcium 3 mg - hyperhomocysteinemia of any etiology. medical foods are intended for the patient who has a limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements, the dietary management of which cannot be achieved by the modification of the normal diet alone1 . l-methyl-b6-b12 is a specially formulated medical food for the dietary support of patients with hyperhomocysteinemia. it also is helpful in managing patients with high total homocysteine concentrations associated with malabsorption of vitamin b12 or suboptimal intake of b vitamins. l-methyl-b6-b12 tablets should always be used under medical supervision. l-methyl-b6∙b12 is contraindicated in patients with known hypersensitivity to any of the components contained in this product. discontinue use if patient exhibits signs of hypersensitivity such as tachycardia, urticaria, or shortness of breath.
l-methyl-b6-b12- levomefolate calcium, pyridoxal phosphate anhydrous, and methylcobalamin tablet, coated
virtus pharmaceuticals llc - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w) - levomefolate calcium 3 mg - hyperhomocysteinemia of any etiology. medical foods are intended for the patient who has a limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements, the dietary management of which cannot be achieved by the modification of the normal diet alone1 . l-methyl-b6-b12 is a specially formulated medical food for the dietary support of patients with hyperhomocysteinemia. it also is helpful in managing patients with high total homocysteine concentrations associated with malabsorption of vitamin b12 or suboptimal intake of b vitamins. l-methyl-b6-b12 tablets should always be used under medical supervision. l-methyl-b6∙b12 is contraindicated in patients with known hypersensitivity to any of the components contained in this product. discontinue use if patient exhibits signs of hypersensitivity such as tachycardia, urticaria, or shortness of breath.
zoladex 10.8 implant goserelin 10.8mg (as acetate) implant syringe
astrazeneca pty ltd - goserelin, quantity: 10.8 mg - implant - excipient ingredients: polyglactin - prostate cancer: palliative treatment of metastatic or locally advanced prostate cancer , where suitable for hormonal manipulation. adjuvant and neo-adjuvant therapy in combination with radiotherapy for the management of locally advanced prostate cancer in men suitable for hormonal manipulation.